Anthropic Confidentially Files for IPO After Raising $65 Billion in a Funding Round at a $965 Billion Valuation

Why It Matters

Anthropic’s public listing could reshape AI market dynamics by granting it broader capital access and potentially eclipsing OpenAI’s Wall Street debut. The move also highlights the high‑stakes valuation race among generative‑AI leaders.

Key Takeaways

• Anthropic filed confidential IPO paperwork, aiming for a fall debut.
• Raised $65 billion at a $965 billion valuation, surpassing OpenAI.
• Q2 revenue forecast $10.9 billion, on track for first profit quarter.
• Legal dispute with Pentagon over supply‑chain risk could threaten billions.
• Goldman Sachs, JPMorgan, Morgan Stanley slated as lead underwriters.

Pulse Analysis

Anthropic’s confidential filing marks a decisive step in the escalating race for an AI‑focused public debut. After securing a $65 billion financing round that lifted its valuation to roughly $965 billion—briefly overtaking OpenAI—the company signaled intent to list as early as this fall. The move positions Anthropic to tap a broader pool of institutional capital, potentially outpacing its rival’s own pending IPO. Investment banks such as Goldman Sachs, JPMorgan Chase, and Morgan Stanley are already being floated as lead underwriters, underscoring the deal’s magnitude. The filing also underscores the broader trend of AI firms seeking public capital.

Financially, Anthropic is riding an unprecedented growth curve. 9 billion, more than double the prior quarter, and a run‑rate that should exceed $50 billion by next month. The company is also on pace for its first profitable quarter, a milestone that could reassure skeptical investors after OpenAI’s recent product reshuffles and missed targets. Such metrics not only validate the $965 billion valuation but also set a new benchmark for AI‑driven enterprises seeking public market credibility. Analysts see the revenue surge as a catalyst for higher market multiples.

Despite the optimism, Anthropic faces headwinds. A Pentagon designation as a supply‑chain risk has sparked a legal battle that could jeopardize billions in government contracts. Moreover, the fierce competition with OpenAI—both racing to broaden AI applications in coding, finance, and healthcare—means market share gains are not guaranteed. Nonetheless, the anticipated IPO could provide the liquidity needed to weather regulatory challenges and fund further R&D. For investors, the listing offers exposure to a rapidly scaling AI platform, while the involvement of top banks suggests a well‑structured offering.